ORA - Oxford University Research Archive

1 - 4 of 4

1

Journal article

Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trial.

Hodgson, SH, Choudhary, P, Elias, SC, et al.
2014-12-05

2

Conference

SAFETY, IMMUNOGENICITY AND IMPACT ON PARASITE MULTIPLICATION RATES OF THE CANDIDATE BLOOD-STAGE VACCINE AMA1-C1/ALHYDROGEL WITH THE NOVEL ADJUVANT CPG 7909 AGAINST BLOOD-STAGE MALARIA CHALLENGE IN HEALTHY MALARIA-NAIVE VOLUNTEERS

Duncan, CJ, Sheehy, SH, Ewer, K, et al.
2010-11-05

3

Journal article

Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909.

Duncan, CJ, Sheehy, SH, Ewer, KJ, et al.
2011

4

Journal article

A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity.

Goodman, AL, Blagborough, AM, Biswas, S, et al.
2011

TO TOP